Literature for AS-101 compound

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2017
1. Hachmo,Y., Kalechman,Y., Skornick,I., Gafter,U., Caspi,R.R. and Sredni,B.
   The small tellurium compound AS101 ameliorates rat crescentic glomerulonephritis: association with inhibition of macrophage caspase-1 activity via very late antigen-4 inactivation
   Front Immunol (2017) 8, 240-240. PubMed  Europe PubMed DOI  PMC  EPMC  I
2007
2. Brodsky,M., Yosef,S., Galit,R., Albeck,M., Longo,D.L., Albeck,A. and Sredni,B.
   The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme
   J Interferon Cytokine Res (2007) 27, 453-462. PubMed  Europe PubMed DOI  I
2005
3. [YEAR:1-2-2005]Cunha,R.L., Urano,M.E., Chagas,J.R., Almeida,P.C., Bincoletto,C., Tersariol,I.L. and Comasseto,J.V.
   Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B
   Bioorg Med Chem Lett (1-2-2005) 15, 755-760. PubMed  Europe PubMed DOI  I
1987
4. [YEAR:12-11-1987]Sredni,B., Caspi,R.R., Klein,A., Kalechman,Y., Danziger,Y., Ben Ya'akov,M., Tamari,T., Shalit,F. and Albeck,M.
   A new immunomodulating compound (AS-101) with potential therapeutic application
   Nature (12-11-1987) 330, 173-176. PubMed  Europe PubMed DOI  I